Diagnosis of pancreatic cancer via1H NMR metabolomics of human plasma
Language English Country Great Britain, England Media print
Document type Journal Article
PubMed
30270368
DOI
10.1039/c8an01310a
Knihovny.cz E-resources
- MeSH
- Amino Acids blood MeSH
- Blood metabolism MeSH
- 3-Hydroxybutyric Acid blood MeSH
- Lactic Acid blood MeSH
- Middle Aged MeSH
- Humans MeSH
- Metabolomics methods MeSH
- Multivariate Analysis MeSH
- Biomarkers, Tumor blood MeSH
- Pancreatic Neoplasms blood diagnosis MeSH
- Proton Magnetic Resonance Spectroscopy MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- Amino Acids MeSH
- 3-Hydroxybutyric Acid MeSH
- Lactic Acid MeSH
- Biomarkers, Tumor MeSH
Metabolic changes induced by pancreatic cancer were investigated by 1H NMR spectroscopy of plasma samples of patients and healthy controls. The acquired data were submitted to multivariate statistical analysis providing clear discrimination between both groups. The most significant differences were found in levels of 3-hydroxybutyrate and lactate. The obtained results (100% sensitivity, 90% specificity) clearly show the potential of 1H NMR spectroscopy in pancreatic cancer diagnosis. Therefore, the NMR-based metabolomics may contribute to the early diagnosis, prevention and/or therapy of diseases in the future. On the other hand, the number of samples in the presented pilot study is limited and has to be significantly increased in the future in order to obtain solid statistical models and to confirm the current findings.
References provided by Crossref.org